Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration.

Saved in:
Bibliographic Details
Title: Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration.
Authors: Izquierdo-Serra J; Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Martin-Pinardel R; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Moll-Udina A; Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Bernal-Morales C; Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Garay-Aramburu G; OSI Araba, Vitoria-Gasteiz, Spain., Sanchez-Monroy J; Miguel Servet Ophthalmology Research Group (GIMSO), Miguel Servet University Hospital, Aragón Institute for Health Research (IIS-Aragón), Zaragoza, Spain., Arruabarrena C; Hospital Universitario Príncipe de Asturias, Madrid, Spain., Fernandez-Hortelano A; Hospital Universitario del Henares, Madrid, Spain., Figueroa MS; Hospital Universitario Ramon y Cajal, Madrid, Spain., Abraldes M; Hospital de Conxo, Santiago de Compostela, Spain., Lavid de Los Mozos FJ; Hospital Punta de Europa, Algeciras, Spain., Zapata MA; Hospital Universitari Vall de Hebrón, Barcelona, Spain., Ruiz-Moreno JM; Hospital Universitario Puerta del Hierro, Madrid, Spain., Broc-Iturralde L; Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Gonzalez-Guijarro J; Hospital Universitario La Princesa, Madrid, Spain., Escobar-Barranco JJ; Hospital Dos de Maig, Barcelona, Spain., Gallego-Pinazo R; Oftalvist Valencia, Valencia, Spain., Parrado-Carrillo A; Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Dotti-Boada M; Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Alforja S; Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Figueras-Roca M; Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Barthelmes D; University Hospital Zurich, Switzerland., Gillies MC; Save Sight Institute, University of Sydney, Australia., Casaroli-Marano RP; Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Department of Surgery, School of Medicine, Universitat de Barcelona, Spain., Zarranz-Ventura J; Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Department of Surgery, School of Medicine, Universitat de Barcelona, Spain. Electronic address: zarranz@clinic.cat.
Corporate Authors: Writing Committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group
Source: Ophthalmology. Retina [Ophthalmol Retina] 2024 Apr; Vol. 8 (4), pp. 350-359. Date of Electronic Publication: 2023 Nov 02.
Publication Type: Observational Study; Multicenter Study; Journal Article
Journal Info: Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2468-6530
DOI:10.1016/j.oret.2023.10.022